These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21495957)

  • 21. Cognitive issues in Parkinson's disease.
    Elmer L
    Neurol Clin; 2004 Oct; 22(3 Suppl):S91-S106. PubMed ID: 15501368
    [No Abstract]   [Full Text] [Related]  

  • 22. The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan.
    Wu CY; Hu HY; Chow LH; Chou YJ; Huang N; Wang PN; Li CP
    PLoS One; 2015; 10(6):e0130993. PubMed ID: 26098910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinpocetine. Monograph.
    Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
    [No Abstract]   [Full Text] [Related]  

  • 25. [Perspectives on the treatment of organic mental disorders by the use of nootropic agents].
    Litvintsev SV; Shamreĭ VK; Reznik AM; Arbuzov AL
    Voen Med Zh; 2002 May; 323(5):59-62. PubMed ID: 12073844
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
    Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
    Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic results with Cerebrolysin in the treatment of dementia.
    Rainer M; Brunnbauer M; Dunky A; Ender F; Goldsteiner H; Holl O; Kotlan P; Paulitsch G; Reiner C; Stössl J; Zachhuber C; Mössler H
    Wien Med Wochenschr; 1997; 147(18):426-31. PubMed ID: 9408984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.
    Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P
    Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrolysin: a multi-target drug for recovery after stroke.
    Brainin M
    Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?
    Lockhart BP; Lestage PJ
    Exp Gerontol; 2003; 38(1-2):119-28. PubMed ID: 12543269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acetylcholinesterase inhibitors for dementia--an update].
    Anghelescu I; Heuser I
    MMW Fortschr Med; 2007 May; 149 Suppl 2():76-8. PubMed ID: 17724973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)].
    Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A hormonal drug melatonin in the treatment of cognitive function disorders in parkinsonism].
    Arushanian EB
    Eksp Klin Farmakol; 2010 Mar; 73(3):35-9. PubMed ID: 20408429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice.
    Ghumatkar PJ; Patil SP; Jain PD; Tambe RM; Sathaye S
    Pharmacol Biochem Behav; 2015 Aug; 135():182-91. PubMed ID: 26071678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
    Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebrolysin and magnesium-B6 in the treatment of side effects of psychotropic drugs].
    Panteleeva GP; Bondar' VV; Krasnikova NI; Raiushkin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(1):37-41. PubMed ID: 11530457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].
    Schmidt R; Marksteiner M; Dal-Bianco P; Ransmayr G; Bancher C; Benke T; Wancata J; Fischer P; Leblhuber CF; Psota G; Ackerl M; Alf C; Berek K; Croy A; Delazer M; Fasching P; Frühwald T; Fruhwürth G; Fuchs-Nieder B; Gatterer G; Grossmann J; Hinterhuber H; Iglseder B; Imarhiagbe D; Jagsch C; Jellinger K; Kalousek M; Kapeller P; Ladurner G; Lampl C; Lechner A; Lingg A; Nakajima T; Rainer M; Reisecker F; Spatt J; Walch T; Uranüs M; Walter A
    Neuropsychiatr; 2010; 24(2):67-87. PubMed ID: 20605003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection and recovery: recent data at the bench on citicoline.
    Hurtado O; Lizasoain I; Moro MÁ
    Stroke; 2011 Jan; 42(1 Suppl):S33-5. PubMed ID: 21164125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotectants in stroke therapy.
    Jeyaseelan K; Lim KY; Armugam A
    Expert Opin Pharmacother; 2008 Apr; 9(6):887-900. PubMed ID: 18377333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.